Quantum Genesis AI Corp. (QGAI) stock: key figures, P/E, revenue and dividend

Materials · United States

Price
0.03 USD
Market cap
1.15 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Quantum Genesis AI Corp. financials

Fiscal year2025
Revenue0.00 USD
Operating income-180,537.00 USD
EBIT-178,037.00 USD
Net income-199,269.00 USD
Diluted EPS – continuing operations-0.01 USD

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Quantum Genesis AI Corp.

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. was incorporated in 2015 and is based in San Diego, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.